首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   228篇
  免费   8篇
财政金融   39篇
工业经济   27篇
计划管理   35篇
经济学   42篇
综合类   3篇
运输经济   3篇
旅游经济   8篇
贸易经济   37篇
农业经济   23篇
经济概况   18篇
邮电经济   1篇
  2023年   1篇
  2021年   3篇
  2020年   3篇
  2019年   8篇
  2018年   5篇
  2017年   8篇
  2016年   7篇
  2015年   4篇
  2014年   16篇
  2013年   29篇
  2012年   8篇
  2011年   13篇
  2010年   4篇
  2009年   9篇
  2008年   8篇
  2007年   10篇
  2006年   3篇
  2005年   5篇
  2004年   8篇
  2003年   4篇
  2002年   5篇
  2001年   2篇
  2000年   6篇
  1999年   5篇
  1998年   3篇
  1997年   2篇
  1996年   5篇
  1995年   2篇
  1994年   1篇
  1992年   4篇
  1991年   5篇
  1990年   4篇
  1989年   2篇
  1987年   3篇
  1986年   1篇
  1985年   5篇
  1984年   1篇
  1983年   3篇
  1982年   5篇
  1981年   2篇
  1980年   2篇
  1979年   2篇
  1978年   2篇
  1977年   3篇
  1976年   2篇
  1974年   1篇
  1970年   1篇
  1966年   1篇
排序方式: 共有236条查询结果,搜索用时 484 毫秒
61.
62.
Abstract

Background: Injectable botulinum neurotoxins are a mainstay of treatment for pediatric spasticity. AbobotulinumtoxinA and onabotulinumtoxinA are both injectable toxin therapies used to treat pediatric lower limb (PLL) spasticity in Canada. The objective of this study was to assess the cost-effectiveness of abobotulinumtoxinA vs. onabotulinumtoxinA in the treatment of PLL spasticity in Canada.

Methods: A probabilistic Markov cohort model with a 2-year time horizon was developed, with health states defined by response to therapy, as characterized by the goal attainment scale (GAS). Based on randomized controlled trial evidence, response to therapy was similar or higher for abobotulinumtoxinA relative to onabotulinumtoxinA; uncertainty was incorporated into model parameters, however, as the two therapies have not been compared head-to-head. Canadian resource use and cost data were incorporated.

Results: In the base case, abobotulinumtoxinA generated 1.48 quality-adjusted life years over the model time horizon, compared to 1.47 for onabotulinumtoxinA. AbobotulinumtoxinA was associated with cost savings of $123 CAD, reflecting lower costs in both medication acquisition and health services. The estimated improvement to quality of life and reduced costs result in an estimate of economic dominance for abobotulinumtoxinA over onabotulinumtoxinA. This dominant result persisted across probabilistic and scenario analyses.
  • Key points for decision makers
  • Based on a review of available clinical evidence, abobotulinumtoxinA was found to have significant and/or numerical efficacy benefits to onabotulinumtoxinA on functional outcomes (Goal Attainment Scale) and tone (Modified Ashworth Scale) and in the treatment of pediatric lower limb spasticity

  • In this cost-effectiveness analysis, abobotulinumtoxinA was found to be associated with greater quality-adjusted life years and lower costs than onabotulinumtoxinA (economically dominant)

  • A limitation of this analysis was the uncertainty around key parameters. Specifically, the lack of head-to-head comparison data for the two therapies, and variable data regarding likely onabotulinumtoxinA dosing in PLL in clinical practice. However, across a range of plausible scenarios, the economic dominant result remained.

  相似文献   
63.
Choice experiments,site similarity and benefits transfer   总被引:1,自引:0,他引:1  
Choice experiments are designed to account for variations in environmental resources and site characteristics, as well as potential implications of these variations for willingness to pay. As a result, choice experiment results may be well suited for benefits transfer. It is unclear, however, whether the flexibility of choice experiments renders the similarity of study and transfer sites less critical for transfer validity. Drawing from identical choice experiments conducted in different Rhode Island communities, this model assesses the extent to which error in function-based benefits transfer is related to the similarity of communities across a variety of observable dimensions. Results suggest that site similarity, at least across some dimensions, influences the validity of choice experiment benefits transfers. However, the use of some measures of similarity as indicators of transfer error may provide misleading results.  相似文献   
64.
Business-to-business relationships are characterized by an exchange between two or more parties. Research has identified several factors that enhance marketing and management in business relationships, mainly with a focus on large manufacturing firms. However, less is known about how service firms develop and maintain international relations during the establishment of a business. To analyze the relevance of the key mediating variable (KMV) model [J. Mark. 58 (1994) 20-38.], which maintains that business-to-business relationship requires commitment and trust, interviews were conducted with five different service entrepreneurs in Sweden, Australia and the UK. The findings demonstrate the importance of commitment, trust, relation termination costs and benefits, shared values and communication between the exchange partners.  相似文献   
65.
66.
67.
68.
69.
70.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号